Qiagen and Nvidia expanded their partnership to integrate Nvidia computing and BioNeMo into Qiagen Digital Insights biomedical knowledgebases. Qiagen said the aim is to increase AI use in target selection and biomarker discovery by applying graph-based AI and accelerated compute across its curated discovery platform. Pilot programs are planned first with broader availability expected after validation.